Reduction of the Uptake by a Macrophagic Cell Line of Nanoparticles Bearing Heparin or Dextran Covalently Bound to Poly(methyl methacrylate)
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 8 (3) , 165-172
- https://doi.org/10.3109/10611860008996862
Abstract
Amphiphilic and fluorescent covalently labelled core-shell nanoparticles based on poly(methyl methacrylate) (PMMA), were prepared by random copolymerisation of N-Vinyl carbazole (NVC) with MMA, initiated on polysaccharidic radicals, yielding diblock copolymers of either dextran-P(MMA-NVC) (Nanodex* particles), or heparin-P(MMA-NVC) (Nanohep* particles). Nanoparticles made from random copolymers of P(MMA-NVC) (PMMA*) were used as controls. The interactions between particles and a J774A1 murine macrophage-like cell line were quantified by direct measurement of the cell-associated fluorescence. The association with the cells occurred within 30 min. Nanodex* and Nanohep* showed considerably less association than the control PMMA* particles. Some of the particle uptake could be attributed to phagocytosis, but more than 50% of the cell-associated fluorescence persisted at low temperature or in the presence of cytochalasin B. The results suggest that both the adsorption and the internalisation processes can be inhibited by the presence of the polysaccharide chains. In conclusion, these results confirm that nanoparticles prepared with heparin or dextran chains on their surface, probably in a brush-like configuration, show "stealth" properties in vitro as had previously been observed in vivo. If this biomimetic approach can also be applied to biodegradable polymers, these systems would provide at least an alternative to PEG-modified particles as long-circulating drug carriers systems or imaging agents.Keywords
This publication has 21 references indexed in Scilit:
- Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation systemBiomaterials, 1997
- A New Model for Evaluation of Biocompatibility: Combined Determination of Neoepitopes in Blood and on Artificial Surfaces Demonstrates Reduced Complement Activation by Immobilization of HeparinArtificial Organs, 1995
- Protein‐rejecting ability of surface‐bound dextran in end‐on and side‐on configurations: Comparison to PEGJournal of Biomedical Materials Research, 1995
- Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes SystemJournal of Pharmaceutical Sciences, 1995
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- The role of complement in inflammation and phagocytosisImmunology Today, 1991
- Large unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Letters, 1987
- Morphological, cytochemical, functional, and proliferative characteristics of four murine macrophage-like cell linesCellular Immunology, 1985
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.The Journal of Experimental Medicine, 1978